References
- Jost LM, Kloke O, Stahel RA. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of newly diagnosed large cell non-Hodgkin's lymphoma. Ann Oncol 2005;16(Suppl. 1):i58–59.
- Elias L, Portlock CS, Rosenberg SA. Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP). Cancer 1978;42:1705–1710.
- Shankland KR, Armitage JO, Hancock BW. Non-Hodgkin lymphoma. Lancet 2012;380:848–857.
- Coiffier B. State-of-the-art therapeutics: diffuse large B-cell lymphoma. J Clin Oncol 2005;23:6387–6393.
- Stein H, Warnke RA, Chan WC, et al. Diffuse large B-cell lymphoma, not otherwise specified. WHO classification of tumours of haematopoietic and lymphoid tissues. WHO press. 4th ed. Lyon: IARC; 2008. p 233–237.
- Delsol G, Campo E, Gascoyne RD, et al. ALK-positive large B-cell lymphoma. Classification of tumours of haematopoietic and lymphoid tissues. WHO press. 4th ed. Lyon: IARC; 2008. p 254–255.
- Milpied N, Deconinck E, Gaillard F, et al. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med 2004;350:1287–1295.
- Stupp R, Mason WP, van den Bent MJ, et al.; Groups, European Organisation. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987–996.
- Osmani A, Masood N. Temozolomide for relapsed primary CNS lymphoma. J Coll Physicians Surg Pak 2012;22:594–595.
- Momota H, Narita Y, Miyakita Y, et al. Acute lymphoblastic leukemia after temozolomide treatment for anaplastic astrocytoma in a child with a germline TP53 mutation. Blood Cancer 2010;55:577–579.
- Van Ginderachter L, Cox T, Drijkoningen R, et al. Non-hodgkin lymphoma after treatment with extended dosing temozolomide and radiotherapy for a glioblastoma: a case report. Case Rep Oncol 2013;6:45–49.
- Makino K, Nakamura H, Hide T, et al. Salvage treatment with temozolomide in refractory or relapsed primary central nervous system lymphoma and assessment of the MGMT status. J Neurooncol 2012;106:155–160.
- Kurzwelly D, Glas M, Roth P, et al. Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status. J Neurooncol 2010;97:389–392.
- Conyers R, Rao A, Solomon B, et al. Editor in Chief: Response to Eyre et al. ALK-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease. Eur J Haematol 2015;94:86–87. 10.1111/ejh.12404. Epub 2014 Jul 28.
- Eyre TA, Khan D, Hall GW, et al. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease. Eur J Haematol 2014;93:455–468. doi: 10.1111/ejh.12360. Epub 2014 May 21. Review.